23andMe, Mirador enter strategic research collaboration

23andMe (ME) and Mirador Therapeutics announced a strategic research collaboration. Under the agreement, Mirador will leverage a targeted set of aggregated, de-identified genetic and phenotypic data from the 23andMe research database and its proprietary Mirador360 development engine to enable target validation and precision medicine.